Abstract
METHODS: W ith Research Ethics Committee approval, to evaluate whether continuous infusion of propofol (Diprivan, AstraZeneca, UK) could protect the liver from warm IRI in vivo, livers of male Sprague-Dawley rats were subjected to 60 minutes of partial normothermic ischemia allowing perfusion to right and caudate lobes and subsequent 45 minutes of reperfusion using a microsurgical clip after 30 minutes of stabilization. Either propofol (Propofol group, n = 11, 10 mg/kg/h) or saline (Control group, n = 11, same volume) was continuously administered during the stabilization period and throughout the experiment via the tail vein. At the end of reperfusion blood and liver tissue samples for SGOT and SGPT, lipid peroxidation assay, and histological examination for a morphometric tissue injury scoring system were taken. Additional eight rats were sacrificed for obtaining normal values of SGOT and SGPT. Data were analyzed using Mann-W hitney-U test and ANOVA with post hoc Scheffe test, P < 0.05 being significant.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
